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Background: Inhalation of low-density helium/oxygen mixtures has been used both to lower the airway resistance
and work of breathing of patients with obstructive lung disease and to transport pharmaceutical aerosols to
obstructed lung regions. However, recent clinical investigations have highlighted the potential for entrainment of
room air to dilute helium/oxygen mixtures delivered through non-rebreather facemasks, thereby increasing the
density of the inhaled gas mixture and limiting intended therapeutic effects. This article describes the development
of benchtop methods using face models for evaluating delivery of helium/oxygen mixtures through facemasks.
Methods: Four face models were used: a flat plate, a glass head manikin, and two face manikins normally used in
life support training. A mechanical test lung and ventilator were employed to simulate spontaneous breathing
during delivery of 78/22 %vol helium/oxygen through non-rebreather facemasks. Based on comparison of inhaled
helium concentrations with available clinical data, one face model was selected for measurements made during
delivery of 78/22 or 65/35 %vol helium/oxygen through three different masks as tidal volume varied between 500
and 750 ml, respiratory rate between 14 and 30 breaths/min, the inspiratory/expiratory ratio between 1/2 and 1/1,
and the supply gas flow rate between 4 and 15 l/min. Inhaled helium concentrations were measured both with a
thermal conductivity analyzer and using a novel flow resistance method.
Results: Face models borrowed from life support training provided reasonably good agreement with available
clinical data. After normalizing for the concentration of helium in the supply gas, no difference was noted in the
extent of room air entrainment when delivering 78/22 versus 65/35 %vol helium/oxygen. For a given mask fitted to
the face in a reproducible manner, delivered helium concentrations were primarily determined by the ratio of
supply gas flow rate to simulated patient minute ventilation, with the inspiratory/expiratory ratio playing a
secondary role. However, the functional dependence of helium concentration on these two ratios depended on
the mask design.
Conclusions: Large differences in mask performance were identified. With continued refinement, the availability of
reliable benchtop methods is expected to assist in the development and selection of patient interfaces for delivery
of helium/oxygen and other medical gases.
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Inhalation of helium/oxygen (He/O2) mixtures has been
explored as a means to lower the airway resistance
and work of breathing of patients suffering from ob-
structive lung disease [1-6], and as a carrier gas to trans-
port pharmaceutical aerosols to obstructed lung regions
[7-12]. These effects stem from the physical properties
of He/O2 mixtures, in particular their low density com-
pared to air [13-16]. As supplied, the He concentration
in therapeutic He/O2 mixtures typically ranges from
60% to 80%, so as to balance between the low density
afforded by high He concentration and the patient’s sup-
plemental O2 requirements. During noninvasive ventila-
tion (NIV) combining He/O2 with pressure support
[1,2], the tight fit of the NIV mask and the elevated pres-
sure in the mask dead space combine to prevent entrain-
ment of ambient room air and ensure that the targeted
He concentration is inhaled by the patient. However,
during unassisted spontaneous breathing, recent clinical
investigations have highlighted the potential for room air
entrainment to dilute He/O2 mixtures delivered through
standard non-rebreather facemasks [17,18], thereby po-
tentially limiting efficacy of He/O2 therapy and certainly
confounding efforts to determine optimal He/O2 mix-
ture concentrations when using non-rebreather masks.
The development of He/O2 delivery strategies aimed
at reducing room air entrainment (preferably while con-
serving gas consumption) will potentially entail design of
purpose-made facemasks or other patient interfaces,
improved means of matching supplied gas flows to pa-
tient demand, and/or use of semi-closed breathing cir-
cuits. Moreover, novel patient interfaces and gas supply
means will be required for other medical gases, for ex-
ample as new applications for nitric oxide, or for sub-
anesthetic delivery of nitrous oxide and xenon, reach
clinical evaluation. In the early-stages of product devel-
opment, the availability of bench apparatus for collection
of test data is advantageous, provided those test data can
be trusted to be representative of use in the clinical set-
ting. Evaluating facemask designs on the bench is par-
ticularly challenging given patient variation in facial
features and size, and tolerance of fit tightness. While
face models have been examined for testing aerosol drug
delivery through facemasks [19,20], little information is
available on the suitability of face models for testing
medical gas delivery interfaces.
The aim of the present study was to compare several
approaches to evaluating He/O2 delivery through non-
rebreather facemasks on the bench. Four different face
models were initially studied, ranging from a flat plate to
more anatomically realistic manikins borrowed from life
support training. Data obtained on the bench were com-
pared with those obtained by Roche-Campo et al. [17] in
a set of six healthy volunteers. Subsequently, a singleface model was selected for a wider investigation of
three different mask designs over a range of supply gas
flow rates and simulated patient breathing patterns.
Methods
Facemasks
Three non-rebreather facemasks were studied, as pic-
tured in Figure 1. These included a Pulmanex Hi-Ox
mask (Viasys Healthcare, Netherlands), a Heliox21 mask
(Intersurgical, UK), and a standard, three-valve reservoir
mask (Intersurgical, UK). While the standard and Hi-Ox
masks were developed to deliver high oxygen concentra-
tions, they have also been used for He/O2 administration.
Bench apparatus
The experimental apparatus is shown schematically in
Figure 2. Patient breathing was simulated using a dual
chamber adult test lung (Michigan Instruments, USA)
with the two chambers connected via a lifting bar. One
chamber, the driving chamber, was connected to a venti-
lator (Neftis ICU; Taema, France) operated in volume
control mode to impose breathing patterns, which varied
in tidal volume between 500 and 750 ml, in respiratory
rate between 14 and 30 breaths/min, and in the ratio of
inspiratory time to expiratory time (ti/te) between 1/2
and 1/1. All experiments were made with a constant (ap-
proximately square waveform) inspiratory flow. The sec-
ond chamber, the breathing chamber, was connected to
the various face models. Facemasks were fit to the face
models, and He/O2 (Air Liquide, France) was supplied
to the facemasks at either 78/22 or 65/35 %vol through
a gas blender (Sentry He/O2 Blender; Cardinal Health,
USA) at flow rates ranging from 4 to 15 l/min.
Face models
Four different face models were evaluated. A sealed
model was constructed simply by fixing the facemasks to
a flat face plate using adhesive putty to create a gas-tight
seal between the mask cuff and the plate. A 22 mm hole
was cut in the face plate to fit an inlet for the throat
described below. Again, this inlet was sealed to the face
plate using adhesive putty. An open model employed a
hollow glass manikin head with a 40 mm diameter hole
cut out at the position of the mouth. For both the open
and sealed models, a ‘throat’ was constructed from
standard 15 mm medical tubing, a 90° elbow connector,
and an additional 15 mm ID/22 mm OD adapter used to
extend the throat to create an inlet at the position of the
mouth. The dead volume between the throat inlet and
the position from which gas was sampled for analysis
was 100 ml. For the open model, Parafilm (Fisher Scien-
tific, France) was used to close-off the mouth opening of
the glass manikin around the throat inlet.
Figure 1 Non-rebreather facemasks evaluated in the present study: a) The Hi-Ox mask, b) the Heliox21 mask, and c) the standard
mask. Black arrows indicate the positions of inhalation valves, while white arrows indicate the position of exhalation valves. The dotted
arrow in a) indicates the position of the anti-suffocation valve.
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also studied. For the Laerdal model, an adult manikin
face (310210; Laerdal, Norway) was fitted over top of the
glass manikin head as shown in Figure 3. The throat was
kept in place, and the mouth opening of the manikin
face was closed around the throat inlet, again using
Parafilm, so as to simulate mouth breathing only. The
Simulaids model employed a manikin face with upperFigure 2 Schematic of the experimental apparatus used to test helium
parabolic resistors (Rp5) placed in the flow paths supplying the right and le
to convert the differential pressure measured across either resistor to a voltairway (BLS Airway Trainer; Simulaids, UK), also shown
in Figure 3. The nostrils of the model were plugged, and
the outlet of the larynx was connected directly to tubing
supplying the breathing chamber of the test lung, with
the throat described above removed. The model had a
second outlet, representing the esophagus, which was
also plugged for all experiments. The total dead volume
of the model was 230 ml./oxygen (He/O2) delivery through facemasks. RR and RL represent
ft compartments of the test lung. ΔP→ V represents transducers used
age signal sent to the data acquisition (DAQ) system.
Figure 3 The Simulaids (left) and Laerdal (right) face models are shown fitted with the Hi-Ox mask.
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Two methods were used to measure delivered helium
concentrations. A thermal conductivity analyzer (KG6050;
Hitech Instruments, UK), calibrated to measure the hel-
ium concentration in binary helium-oxygen mixtures,
drew a continuous sample of 200–300 ml/s from tubing
supplying the breathing chamber of the test lung. As spe-
cified by the manufacturer, the T90 response time of this
analyzer is 20 seconds; accordingly, for each experiment,
the measured helium concentration was allowed to reach
steady state over several breaths before being recorded.
In addition, a flow resistance technique was used to
obtain intra-breath measures of the helium concentra-
tion. Parabolic resistors (Rp5, PneuFlow; Michigan
Instruments, USA) were inserted into the flow paths
supplying the two breathing chambers of the test lung.
The differential pressure across each of these resistors
was monitored and recorded using pressure transducers
(PX277-05D5V; Omega Engineering Inc, USA) and Lab-
VIEW data acquisition software (National Instruments,
USA). The pressure drop across these resistors depends
on both the gas flow rate and density [13]; accordingly,
on the driving side of the test lung, where the gasdensity was known to be that of air, the resistor served
as a differential pressure flow sensor. This flow measure-
ment, along with the pressure drop measured across the
resistor positioned on the breathing side, allowed the
density (and in turn the helium concentration) of the
gas on the breathing side to be determined, based on
calibration data previously obtained by supplying gas to
the resistor at known flow rates and helium concentra-
tions. For all experiments, both the thermal conductivity
analyzer and the flow resistor method were used to
measure delivered helium concentrations.
When using the Laerdal and Simulaids face models, it
was found in preliminary experiments that small adjust-
ments made when fitting masks to the faces produced
large changes in measured helium concentrations. Fur-
thermore, the quality of the fit was difficult to assess
visually. As a consequence, masks were fit to these face
models while supplying He/O2 at 15 l/min and adjusting
the fit to produce the highest possible helium concentra-
tion, as monitored using the thermal conductivity
analyzer. The mask was then left in place and not
adjusted while a series of measurements were performed
at varying supply flow rate or breathing pattern.
Table 1 Average inhaled helium concentrations measured
on the bench and in healthy adult subjects [17]









Hi-Ox 15 52.2 54.3 60.1 (52.3 - 67.8)
12 49.4 52.4 53.5 (42.5 - 66.0)
10 47.1 46.2 45.0 (30.5 - 59.9)
7 43.1 37.4 41.5 (26.3 - 52.8)
Heliox21 15 37.9 32.9 54.9 (35.4 - 69.9)
12 34.1 28.9 46.1 (30.7 - 57.7)
10 31.7 25.3 38.3 (31.1 - 47.0)
7 27.2 20.6 28.2 (18.8 - 35.3)
Standard 15 36.5 42.1 50.9 (41.4 - 63.1)
12 32.7 36.3 42.2 (30.5 - 54.6)
10 29.6 31.6 36.7 (26.3 - 43.3)
7 24.9 26.1 26.7 (20.9 - 32.3)
Martin et al. Medical Gas Research 2012, 2:31 Page 5 of 11
http://www.medicalgasresearch.com/content/2/1/31Results and discussion
Comparison to clinical data
Experiments were first performed with all four face
models using the Hi-Ox mask supplied with 78/22 He/
O2. These were made at a tidal volume of 500 ml and re-
spiratory rate of 30 breaths/min to match the average
breathing parameters recorded during the in vivo mea-
surements performed on healthy adults using the same
mask at resting conditions by Roche-Campo et al. [17].
The ratio ti/te was fixed at 1/2. Figure 4 compares the
average inhaled helium concentrations measured with
the thermal conductivity analyzer for the four face mod-
els with the mean and range of values measured in vivo.
Concerning the face models, the sealed and open models
represent upper and lower extremes in delivered helium
concentrations, with values obtained for the Laerdal and
Simulaids models falling in between. Little difference
was observed between the average helium concentra-
tions measured for the Laerdal and Simulaids face mod-
els, and concentrations measured using either of these
models were in reasonable agreement with mean values
measured in vivo in healthy adults. The series of experi-
ments was repeated for the Heliox21 and standard face-
masks using only the Laerdal and Simulaids models, and
results are presented in Table 1. Again, agreement with
mean values measured in vivo was good, though when
testing the Heliox21 mask on the Simulaids model, he-
lium concentrations delivered on the bench tended to lie
just below the lower range of the in vivo dataset for the
same mask.Figure 4 Average inhaled helium concentrations for the Hi-Ox mask a
(He/O2) 78/22. For the clinical data [17], error bars represent the limits of t
other columns, data was obtained from bench measurements made using
accuracy of the analyzer.Helium concentration measurement
The response time of the thermal conductivity analyzer
was sufficiently slow that measured values repre-
sent time-averaged helium concentrations over several
breaths. In contrast, using the flow resistor method it
was possible to resolve variation in inhaled helium con-
centration within a single breath. Example data is shown
in Figure 5, which was taken for the Hi-Ox mask sup-
plied with 10 l/min of 78/22% He/O2 and fit to each of
the four face models. All data shown in Figure 5 were
obtained at a tidal volume of 500 ml, a respiratory ratere displayed for a range of supply flow rates of helium/oxygen
he range of values measured for six healthy, adult subjects. For all
the thermal conductivity analyzer. Error bars represent the ±2%
Figure 5 An example of data obtained using the flow resistance method for determining inhaled helium concentrations, taken for the
Hi-Ox mask supplied with 10 l/min of 78/22% helium/oxygen (He/O2), while ventilating at 30 breaths/min with a tidal volume of
500 ml and a ratio ti/te of 1/2. Each curve is an average of data obtained over seven consecutive breaths. Also shown is a representative trace
showing the inspiratory flow pattern.
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Figure 5 is a representative trace showing the inspiratory
flow pattern. Note that helium concentration data are
not reported in Figure 5 at the start and end of the
breath. This is a limitation of the measurement ap-
proach; during periods of rapid flow rate increase or de-
crease, instantaneous flow rates in the driving and
breathing sides of the test lung are not equal, with the
breathing chamber generally lagging the driving cham-
ber. As a result, the flow rate derived from the pressure
drop measured across the resistor on the driving side is
different from the flow rate on the breathing side, and
will lead to errors if used in the derivation of the helium
concentration as described above.
Nevertheless, several useful pieces of information are
conveyed in Figure 5. First, even for the sealed model,
the delivered helium concentration falls off towards the
end of the breath. This should not be surprising consid-
ering the ratio of gas supply flow relative to the simu-
lated patient demand. At a tidal volume 500 ml and
respiratory rate of 30 breaths/min, the inhaled minute
volume is 15 l/min. Accordingly, supplying 10 l/min to a
non-rebreather mask requires that an additional 5 l/min
of gas be entrained from the room every minute. With
the mask tightly sealed to the faceplate, this can be con-
sidered a controlled room air dilution, in that dilution
occurs through an anti-suffocation valve, positioned on
the mask’s supply manifold, and towards the end of the
breath, once the reservoir bag is emptied. For the other
three face models studied, where leaks occurred betweenthe mask cuff and the face, there was an additional un-
controlled dilution, for which the location and timing
during the breath are not obvious. In these cases, the
inhaled helium concentration never reached the 78%
contained in the supply flow.
Still with reference to Figure 5, all four curves initially
rise near the beginning of the breath before later falling.
We hypothesize that the former effect occurred due to
inhalation of gas from the combined dead volumes of
the models and masks. The helium concentration in the
dead volume would be that of gas expired from the
breathing chamber, and as such would be lower than
that of the source gas. Therefore, it is likely that inhaled
helium concentrations initially rose as fresh gas from the
source flow and reservoir bag washed into the dead vol-
ume, before peaking and then falling off as the reservoir
emptied. Such an effect could also explain the different
pattern seen for the Simulaids model as compared to the
Laerdal and open models, with the flatter curve for the
Simulaids model linked to its larger dead volume.
Figure 6 compares helium concentrations measured
using the flow resistor method and averaged over an in-
halation with those measured by the thermal conductiv-
ity analyzer. As seen the two methods were in close
agreement, which can be viewed as a validation of the
flow resistor method, but also as evidence that the
steady-state reading on the thermal conductivity
analyzer did indeed represent a time-averaged helium
concentration. Given its ease of use and commercial
availability, the thermal conductivity analyzer seems a
Figure 6 The time-averaged inhaled helium concentration,
[He]avg, measured using the flow resistance method is plotted
against that measured by the thermal conductivity analyzer.
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ing procedures across laboratories.
Parameter study
In an effort to further investigate the performance of the
three masks, additional experiments were conducted
over the full parameter range described in the Methods
section, using only the Simulaids model. This model was
chosen primarily because it was used as supplied by theFigure 7 The normalized delivered helium concentration, [He]delivered/
flow rate and minute ventilation, Qs/VE, for each of the three masks t
For comparison, trend lines are also shown for each mask. Error bars represmanufacturer without modification, and as such would
lend itself most easily to use in other laboratories.
Figure 7 displays data from the full range of the experi-
ments. Delivered helium concentrations are plotted
against the ratio of supply flow rate to minute volume
(QS/VE). As experiments were conducted with both 78/
22 and 65/35% He/O2, delivered helium concentrations
were normalized by the supplied concentration. With
this normalization, data obtained using either mixture
appear to follow the same trend. That is to say, the rela-
tively small differences in gas properties between 78/22
and 65/35% He/O2 [16] did not influence room air en-
trainment, such that results obtained when testing with
one He/O2 mixture can be readily extrapolated to pre-
dict inhaled concentrations that would be delivered
when supplying a different He/O2 mixture, at least so
long as the helium concentration in those mixtures
ranges between 65 and 78%.
Again with reference to Figure 7, two regions of the
curves can be defined. First, when the ratio Qs/VE is less
than one (that is when minute ventilation exceeds the
supply flow rate) the masks can be considered to be
undersupplied. In this case, the Hi-Ox mask outper-
formed both the standard mask and the Heliox21 mask.
This is likely a result of the superior function of the ex-
piratory valve on the Hi-Ox mask. As has been noted by
previous investigators [21], expiratory flap-valves placed
on standard masks permit room air entrainment during
inhalation. By replacing these with a valve positioned in
the gas supply manifold, which remains closed during
inhalation, the design of the Hi-Ox mask promotes[He]supplied, is plotted against the ratio between the supply gas
ested, supplied with 78/22 or 65/35 %vol helium/oxygen (He/O2).
ent standard deviations around mean values (n = 3).
Figure 8 The normalized delivered helium concentration, [He]delivered/[He]supplied, is plotted against a composite parameter that
includes the ratio between the supply gas flow rate and minute ventilation, Qs/VE, and the ratio between inspiratory and expiratory
times, ti/te, for a) the Hi-Ox mask, b) the Heliox21 mask, and c) the standard mask. Error bars represent standard deviations around mean
values (n = 3). For each mask, the exponents in the composite parameter were determined through a least-squares fit of Equation (1) to the
experimental data. Best-fit curves, and associated R2 values, are shown for each mask.
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entrainment [21]. This sequential function was clearly
observable when conducting the experiments, whereas
for the other two masks the reservoir bags did not com-
pletely empty, even when the masks were undersupplied.
When the ratio Qs/VE exceeded one, such that the
masks can be said to be oversupplied, inhaled helium
concentrations delivered through the standard mask
approached those delivered through the Hi-Ox mask,
while concentrations delivered through the Heliox21
mask remained lower. We hypothesize that as the gas
supply becomes increasingly high relative to patient de-
mand, the conserving function provided by the reservoir
becomes less critical, and that instead it is the relative
resistance of the supply flow path compared to that of
uncontrolled leak paths that determines room air en-
trainment. On the Heliox21 mask the inspiratory valve is
positioned further from the patient compared to the
standard mask, and the resulting small increase in resist-
ance between the fresh gas supply and the patient may
promote entrainment of air through leak paths.
Differences in mask performance are further investi-
gated in Figure 8. Data obtained for each mask were fit
with functions of the form:
He½  delivered
He½  supplied






where the constants A, B, C, and D were determined for
each mask by least-squares fitting, and are provided in
Table 2. The error function (erf ) is defined in the Ap-
pendix, and was selected here based solely on goodness
of fit to the data in comparison with several other func-
tions of similar shape.
Examining equation (1), the ratio QS/VE provides a
measure of the supply gas flow relative to patient de-
mand as discussed above. The ratio between the inspira-
tory and expiratory times (ti/te) was included because
with all else held constant, changes to this ratio affect in-
spiratory flow rates, which play a role in determining the
relative resistances of supply and leak flow pathways.
The absolute values of the constants C and D, relative to
one another, provide an indication of the relative sensi-
tivity of delivered helium concentrations to these two
terms. For all three masks, the ratio QS/VE was theTable 2 Best-fit coefficients used in equation 1 for each
facemask
Coefficient
Mask A B C D
Hi-Ox 0.7391 0.8601 0.7233 −0.3210
Heliox21 0.8096 0.6169 0.7478 0.1950
Standard 0.8454 0.5460 0.8694 −0.1001dominant term. Of further interest, the coefficient D was
opposite in sign for the Heliox21 mask than for
the other two masks. That is to say, for the Hi-Ox
and standard masks, increasing inspiratory times, asso-
ciated with lower inspiratory flow rates, tended to
increase delivered helium concentrations, whereas for
the Heliox21 mask the effect was opposite. This result
may be related to the hypothesis provided above, in that
for the Heliox21 mask lower flow rates tended to favor
flow through leaks over that from the fresh gas supply;
however, no firm conclusions should be drawn without a
more detailed analysis of the underlying fluid mechanics.
Finally, though the data shown in Figure 8 collapse
tightly when plotted against the two ratios, Qs/VE and ti/
te, it is important to note that our methodology included
a procedure to fit the masks to the face model in a re-
producible manner. Clearly, variation in the quality and
tightness of fit between the mask cuff and the face will
affect delivered gas concentrations, and this variation is
not captured in the experiments reported here.
Suggestions for improved face models
While the bench data reported herein were in reasonable
agreement with available clinical data, a number of
points could be improved in future test designs. First,
even though masks were adjusted to produce as good a
fit as possible, the delivered helium concentrations
determined using the Laerdal and Simulaids models
tended to fall near, or in some cases even below, the
lower range of values measured in humans. Some dis-
crepancy may be expected due to variation in individual
subjects’ breathing patterns around the average values
that were reproduced on the bench; however, tactile
examination of the face models suggests that they are
both smoother and harder than a typical human face.
Given that neither face model was specifically designed
for the purpose of mask testing, it may be that a
purpose-built model, for example one that simulates a
layer of soft tissue over a hard bone-like structure, will
allow clinical mask performance to be more accurately
reproduced. Borrowing from evaluation of masks used
for aerosol delivery, such a model could also allow deliv-
ered gas concentrations to be assessed as a function of
the force with which the mask is applied to the face
[19,20,22], with an ideal mask maintaining high concen-
trations at low force. To enable such assessment, a
purpose-built model should include the entire head (in
contrast to the Simulaids face model selected for the
present study) given that facemasks used for gas delivery
include a variety of straps or harnesses that secure
around the back of the head. Potential differences be-
tween oral and nasal breathing also merit investigation,
especially for applications where variation in breathing
route over time or between patients is expected.
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As new applications of medical gases reach the stage of
clinical evaluation, the need for novel patient interfaces
and gas supply means will increase. In the present work,
two face manikins normally used in life support training
were incorporated into a bench top model for assessing
delivery of He/O2 through facemasks, and shown to re-
produce available clinical data with reasonable accuracy.
Experiments were then conducted to explore variation
in delivered helium concentrations between three non-
rebreather facemasks, and large differences in mask per-
formance were identified. With continued refinement, it
is anticipated that the availability of reliable benchtop
methods for evaluating facemask and other patient inter-
face designs will help to accelerate the development
process and assist in demonstrating clinical effectiveness
of medical gases.
Appendix
The error function is a mathematical function of the
form








which owes its name to its original use in measurement
theory, but is now used more widely in various branches
of mathematics and engineering.
The error function is included as a built-in function in
most mathematical software packages, and is available in
Microsoft EXCEL after installation of the Analysis Tool-
Pak add-in.
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